Cross Country Healthcare Q3 revenue down 29% YoY to $315M; EPS $0.08

CROSS COUNTRY HEALTHCARE INC

2024-Q3 EPS reported -$0.32 revenue$1,034,064,000

Revenue of $315.1M fell 29% YoY; gross margin 20.4%, down 160 bps.
Net income of $2.6M ($0.08 diluted EPS) vs net loss of $0.28 in Q3 2023.
Adjusted EBITDA $10.3M, down 62% YoY; adjusted EPS $0.12 vs $(0.27).
Revenue down 7% sequentially; net income up 116% QoQ.
Operating cash flow $7.5M, down 89% YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.